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SUMMARY
Pancytopenia can rarely complicate Grave’s disease.  It can
be due to uncontrolled thyrotoxicosis or as a result of rare
side effect of antithyroid medication. Pernicious anemia
leading to Vitamin B12 deficiency is another rare associated
cause. We report a case of a patient with Grave’s disease
and undiagnosed pernicious anemia whom was assumed to
have antithyroid drug induced pancytopenia. Failure to
recognize this rare association of pernicious anemia as a
cause of pancytopenia had resulted in delay in treatment
and neurological complication in our patient. 
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CASE REPORT
A 48 year-old gentleman with long standing Grave's disease
presented with giddiness, lethargy and reduced effort
tolerance for 3 weeks. Apart from carbimazole 10mg and
propranolol 20mg twice daily, he was not on any other
medication. He was a chronic smoker of 10 pack years and
social alcohol drinker. He had no other medical illnesses. On
examination, he was pale, but not jaundiced. He had mild
exophthalmos and a small diffuse goiter but was clinically
euthyroid. There was no hepatosplenomegaly. Examination
of the cardiovascular and respiratory systems yielded no
abnormalities. 
Full blood count showed pancytopenia, with normochromic
normocytic anemia [hemoglobin of 8.7g/dL, MCV 87.2fL,
MCHC 34.4q/L], total white count of 3,200/uL (Neutrophil
count 1,160/uL), and platelet counts of 48,000/uL.
Reticulocyte count was 0.87%. Peripheral blood film showed
microcytic normochromic red blood cells with anisocytosis,
macrocytes and tear drop cells. There was no nucleated red
blood cell. There was leucopenia with hypersegmented
neutrophils but no blast cells, platelet clumping or giant
platelet. Thyroid function and liver function tests were within
normal limits except for elevated total bilirubin at 28umol/L
with predominantly indirect bilirubinaemia. Coomb's tests
were negative for both direct and indirect anti-human
globulin tests. Iron studies showed no feature of iron
deficiency. 
He was transfused with 3 pints of packed cells and was
treated as carbimazole-induced pancytopenia. The anti-
thyroid medication was ceased and he received radioactive
iodine treatment for his thyrotoxicosis. He was then started
on L-thyroxine replacement when he developed
hypothyroidism. 
He presented 11 months later with one month history of
progressive difficulty in walking.  On neurological
examination, there were no muscle wasting. His tone and
power were normal. Reflexes were normal in his upper limbs
but absent in his lower limbs. He was severely ataxic on his
feet with loss of proprioception and vibration in his lower
limbs but intact sensation to pin prick and light touch. There
were no other signs of cerebellar syndrome, such as
dysdiadokokinesia, dysmetria and nystagmus. Other
examination was unremarkable except for presence of
atrophic glossitis.
Full blood count again showed pancytopenia (hemoglobin
8.7g/dL, total white count 3,300/uL, platelet 69,000/uL) with
peripheral blood film showing many hypersegmented
neutrophils consisting of 23% of the blood film. Lactate
dehydrogenase level was raised at 2420u/L (normal 140-
180u/L). Thyroid function, renal function and liver function
tests were otherwise normal. 
A diagnosis of megaloblastic anemia secondary to Vitamin
B12 deficiency was made and confirmed by low B12 level of
107pg/mL (normal 211-911pg/mL) with normal folate level
10.5ng/mL (normal >2.8ng/mL). Dietary history excluded
nutritional deficiency or alcohol abuse.
Oesophagoduodenoscopy showed atrophic gastritis with
small pre pyloric ulcer.
He was started on intramuscular cyanocobalamin at
therapeutic dose with dramatic resolution of his neurological
impairment. One day after starting treatment, he could
ambulate with support and four days later he could
ambulate independently. Subsequent investigation revealed
positive intrinsic factor antibody supporting the diagnosis of
pernicious anemia as the underlying cause of his vitamin
B12 deficiency.
DISCUSSION
Pancytopenia can complicate Grave’s disease and it can be
due to different aetiologies. First of all, untreated
thyrotoxicosis itself has been associated with pancytopenia,
which usually resolves after treatment of thyrotoxicosis1. Low
Boon-Hua reported 17 patients with hyperthyroidism
associated with pancytopenia from year 1981 till 2008 and
found that all of them had resolved blood counts when they
